SEC Form 4 · accession 0001104659-18-071675
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 3:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 3, 2018 | S | 1,089 | $22.00 | D | 53,119 | D | |
| Common StockF3 | holding | — | — | — | 99,668 | I | See footnote | |
| Common StockF4 | holding | — | — | — | 5,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2018.
- F2Includes 905 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 30, 2018.
- F3The shares are held of record by the Zhou Family Trust for which the reporting person serves as a trustee.
- F4The shares are held of record by the reporting person's spouse.